169 related articles for article (PubMed ID: 35116879)
1. Five tumor-associated autoantibodies expression levels in serum predict lung cancer and associate with poor outcome.
Li S; Ma Y; Xiong Y; Zhang P; Wang X; Wang Y; Yang Y
Transl Cancer Res; 2019 Aug; 8(4):1364-1373. PubMed ID: 35116879
[TBL] [Abstract][Full Text] [Related]
2. The role of autoantibody detection in the diagnosis and staging of lung cancer.
Wang Y; Jiao Y; Ding CM; Sun WZ
Ann Transl Med; 2021 Nov; 9(22):1673. PubMed ID: 34988182
[TBL] [Abstract][Full Text] [Related]
3. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
Ren Z; Ding HM; Qian X; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
[No Abstract] [Full Text] [Related]
4. The role of seven autoantibodies in lung cancer diagnosis.
Luo B; Mao G; Ma H; Chen S
J Thorac Dis; 2021 Jun; 13(6):3660-3668. PubMed ID: 34277058
[TBL] [Abstract][Full Text] [Related]
5. Seven tumor-associated autoantibodies as a serum biomarker for primary screening of early-stage non-small cell lung cancer.
Chen P; Lu W; Chen T
J Clin Lab Anal; 2021 Nov; 35(11):e24020. PubMed ID: 34555232
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic efficiency of seven autoantibodies in lung cancer.
Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L
Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214
[TBL] [Abstract][Full Text] [Related]
7. Application Value Analysis of Seven-Autoantibody Panel in the Lung Cancer Screening in Yunnan.
Li W; Sun Y; Xu N
Comput Intell Neurosci; 2022; 2022():2368155. PubMed ID: 35832243
[TBL] [Abstract][Full Text] [Related]
8. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
[TBL] [Abstract][Full Text] [Related]
9. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer.
Ma H; Wu T; Zhang Q; Ding Q
BMC Pulm Med; 2024 May; 24(1):250. PubMed ID: 38773432
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of seven autoantibodies combined detection in the diagnosis of lung cancer.
Mu Y; Xie F; Sun T
J Clin Lab Anal; 2020 Aug; 34(8):e23349. PubMed ID: 32372513
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of autoantibodies combined with tumor markers in the detection of lung cancer.
Mu Y; Li J; Xie F; Xu L; Xu G
J Clin Lab Anal; 2022 Aug; 36(8):e24504. PubMed ID: 35596744
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography.
Liu X; Shen Q; Wen Y; Jiang Z; Ma Z; Zeng P; He J; Liao Y; Huang Y; Huang J
Am J Clin Oncol; 2024 Apr; 47(4):149-154. PubMed ID: 38054473
[TBL] [Abstract][Full Text] [Related]
13. Early detection of lung cancer by using an autoantibody panel in Chinese population.
Ren S; Zhang S; Jiang T; He Y; Ma Z; Cai H; Xu X; Li Y; Cai W; Zhou J; Liu X; Hu X; Zhang J; Yu H; Zhou C; Hirsch FR
Oncoimmunology; 2018; 7(2):e1384108. PubMed ID: 29308305
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer.
Xu Y; Zhang W; Xia T; Liu Y; Bi Z; Guo L; Xie W; Xiang Y; Xu Z; Yu Z; Li Y; Bai L
Front Oncol; 2023; 13():1022331. PubMed ID: 36874112
[TBL] [Abstract][Full Text] [Related]
15. An analysis of the influencing factors of false negative autoantibodies in patients with non-small cell lung cancer.
Wang A; Hao Y; Huo Y; Xu X; Zhang Y
Front Oncol; 2024; 14():1358387. PubMed ID: 38800369
[TBL] [Abstract][Full Text] [Related]
16. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer.
Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y
Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959
[No Abstract] [Full Text] [Related]
17. Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features.
Xu L; Chang N; Yang T; Lang Y; Zhang Y; Che Y; Xi H; Zhang W; Song Q; Zhou Y; Yang X; Yang J; Qu S; Zhang J
Front Oncol; 2022; 12():883543. PubMed ID: 35530343
[TBL] [Abstract][Full Text] [Related]
18. Performance Evaluation of an Enzyme-Linked Immunosorbent Assay for Seven Autoantibodies in Lung Cancer.
Yin-Yu M; Fu-Yi X; Fei-Bo W; Ri-Yi Z; Xiao-Lin Y
Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969073
[TBL] [Abstract][Full Text] [Related]
19. Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer.
Chen SS; Li K; Wu J; Peng ZY; Wang ZD; Wang JC; Xu CW; Zhu CL; Li BC; Ren H; Tang SC; Sun X
J Cancer Res Clin Oncol; 2021 Jan; 147(1):223-233. PubMed ID: 32691153
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
